Individuals whose stage III colon cancer tumors express CEMIP below the median lived an average > 8.6 years longer than stage III colon cancer cases whose tumor CEMIP levels were above the median, a dramatic difference in patient survival. The gene discussed is CEMIP; the disease is neoplasm.